The path to receiving the RO1 grant was made possible in part by the Sky Foundation Inc., which provided initial seed funding for Dr. Azmi. The seed funding helped generate critical data to develop a strong grant application. The foundation has funded Dr. Azmi’s collaborative research efforts since 2015, totaling more than $122,000. The Sky Foundation, based in Bloomfield Hills, Mich., raises awareness and advances research for the early detection and treatment of pancreatic cancer.
I am extremely pleased that Dr. Azmi has received such a prestigious RO1 grant, said Gerold Bepler, M.D., Ph.D., president and CEO of the Karmanos Cancer Institute. It is extremely difficult to receive such a grant and it speaks highly of the innovative research conducted by Karmanos clinical and scientific researchers. Dr. Azmi’s work represents a significant step forward in finding a more effective treatment for such a challenging disease. It’s gratifying that the National Institutes of Health and the National Cancer Institute recognize the ability of our researchers to develop new cancer treatment pathways.
Read the full article here!